CLPTClearPoint Neuro, Inc.
Price
-60%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality strong, a flag to check, growth steady, the market undecided.
Charts
As reported to the SEC, without any scoring.
ClearPoint Neuro, Inc. (CLPT) reported revenue of $11M in Q2 2026 (quarter ended Jun 30, 2026), up 18% from the same quarter a year earlier. That came with a gross margin of 62% and net loss of $11M. For the full year FY2025, revenue was $37M (+18% year on year) and net income −$26M. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 3, 2026ClearPoint Neuro Reports Second Quarter 2026 Results.Earnings release · press release
- May 21, 2026The annual meeting of the stockholders of ClearPoint Neuro, Inc. (the “Company”) was held on May 20, 2026 (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted to approve the adoption of the ClearPoint Neuro, Inc. Seventh Amended and Restated 2013 Incentive Compensation Plan (the “Plan”)Director or officer change · Form 8-K
- May 13, 2026ClearPoint Neuro Reports First Quarter 2026 Results.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.